PTP-PEST discovery could impact treatment of Multiple Sclerosis
From the MSRC:
The internationally-renowned scientific journal Immunity, from the Cell Press group, published online recently, and will publish in its August 27 print issue, the results of a study conducted by a team of researchers led by Dr. Andre Veillette, Director of the Molecular Oncology research unit at the Institut de recherches cliniques de Montreal (IRCM).
Their scientific breakthrough could have an impact on the treatment of multiple sclerosis and other autoimmune diseases, which affect tens of thousands of Canadians. For more click here.